Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

All Conditions

Digestive System Diseases

Skin and Connective Tissue Diseases

Gland and Hormone Related Diseases

Blood and Lymph Conditions

Immune System Diseases

Nervous System Diseases

Rare Diseases

Behaviors and Mental Disorders

Lung Neoplasms

Stomach Neoplasms

Breast Neoplasms

Pancreatic Neoplasms

Lymphoma

Leukemia

Hematologic Neoplasms

Liver Neoplasms

Brain Neoplasms

Hematologic Diseases

Stomach Cancer

Pancreatic Cancer

Quality of Life

Lymphosarcoma

Biliary Tract Cancer

Brain Tumor, Childhood

Being referred to palliative care team before totally terminating their chemotherapy among adult participants.

Being referred to palliative care team when their last chemotherapy is ended among adult participants.

haven't been under the palliative care among adult participants

receiving the palliative care among pediatric participants

haven't received the palliative care among pediatric participants

Palliative Care Team provide a self-learning booklet, medical treatment and consultation about Advance Care Planning with chemotherapy by oncologist.

Early palliative care

Palliative Care Team provide a routine hospice care the same as other patients who doesn't participate this study after the chemotherapy is totally terminated

Routine hospice care

Young Ho Yun, MD-PhD

This study evaluates the change of quality of life, treatment decision and utilization of health care depending on the use of palliative care in advanced cancer patients by a prospective cohort study. Participants will be separated into different groups by their intentions for using palliative care. Every participant will carry out the questionnaire per 3 months. This cohort study will be ended a year after each participant enrolls. However, if the participant didn't survive during this study, the caregivers will be asked to fill out additional questionnaire after 3 months of the death.

Patients with advanced cancer report physical, emotional, social and economic problems that may be due to the cancer itself or its treatment. Previous studies have shown the benefit of early palliative care in oncology. However, many Korean patients tend to start palliative care late even in general hospital. Because of the late start of palliative care, the burden of medical expenses increases, on the other hand, the quality of life of terminally ill patients decrease.

In this study, the use of palliative care in advanced cancer patients will be evaluated by a prospective cohort study. The goals of this study are as follow:

First, the clinical, psycho-social, and cognitive factors affecting quality of life, decision making, and hospital utilization (palliative medical team medical treatment, hospice and medical care) of patients with advanced stage cancer will be investigated.

Second, this study will explore the effects of age-specific characteristics on quality of life and care.

Third, an index, which reflects age-specific characteristics and predicts the time and content of terminal care will be developed. Improvements on the quality of life and care of patients with advanced stage of cancer or metastatic cancer are expected to establish effective terminal care strategies through this study.

The patients' symptom and quality of life, choice of medical care, advance care planning and caregiver's burden of care will be evaluated every 3 months after confirming the willingness to use palliative care for cancer patients. 3 months after the death, a caregiver evaluation will be conducted and hospice use, medical expenses will be analyzed.

Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients

Change of Quality of Life, Treatment Decision and Utilization of Health Care Depending on the Use of Palliative Care in Adult and Pediatric Patients With Advanced Stage of Cancer: a Prospective Cohort Study

to measure quality of life of adult patients developed by European Organisation for Research and Treatment of Cancer for Palliative Care

Patients survival and POLST(Physician Order for Life-Sustaining Treatment) documentation whether patients survive during the study period and write POLST documentation (Since POLST has no legal form in Korea, it is based on the format of each institution.)

"Patient Health Questionnaire-9 items" is used as assessment tool to measure depression of both patients and their caregivers by completing the questionnaire.

"Decision Conflict Scale" is used as assessment tool to measure a level of decision conflict in treatment of both patients and their caregivers by completing the questionnaire.

to measure the awareness of patients' status of prognosis in both patients and caregivers through two questions in the questionnaire. The first question is about the idea of the possibility of curing the patient's disease and asks patients thought about whether treatment is available for cure and prolong survival. The second question concerns the life expectancy of the patient.

to measure the perceived holistic health status(physical, mental, social, spiritual and general) in both patients and caregivers. caregivers (The patient is asked to answer the perceived health status into five stages.)

To measure Daily functional skills in elderly only in 65-year or order patients.

Direct medical cost will be collected through National Health Insurance Corporation and Indirect cost will be collected by caregiver's questionnaire. In addition, "EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L)" tool will be included in the patient's questionnaire to measure the condition of patients at the same time.

In order to analyze the cost effectiveness, investigate the frequency of use of early palliative care programs, the use of life-sustaining treatment and hospicee, and the use of complementary and alternative medicine(CAM). CAM include Chinese medicine, aromatherapy, diet, and yoga, etc.

to assess the patient's awareness of advanced care planning and willingness to construct advanced care planning. The preference for palliative care is divided according to the life expectancy. Investigate the preference of palliative care in each case - if the life expectancy is within a year, within a few months, or within a few weeks.

To measure mental, social, spiritual quality of life of both patients and caregivers

"Pediatric Quality of Life Inventory(Peds QL)" will be used as assessment tool for QOL among pediatric patients.

Seoul National University Bundang Hospital

National Cancer Center, Korea

Kyunghee University Medical Center

Severance Hospital

Gyeongsang National University Hospital

Chungnam National University Hospital

Chonbuk National University Hospital

Ewha Womans University Mokdong Hospital

Daegu Fatima Hospital

Chonnam National University Hospital

Keimyung University Dongsan Medical Center

Hallym University Medical Center

Asan Medical Center

National Evidence-Based Healthcare Collaborating Agency

National Institute of Health, Korea

National Clinical Research Coordination Center, Seoul, Korea

Ulsan University Hospital

Seoul National University Hospital

Clinical Professor

Mia Sommer, MHsc

Mia Sommer, MHSc

Lise T Elkjær

The aim of this study is to adjust and test an existing internet-based tool for collecting patient-reported outcome measures and to use the internet-based tool in an multidisciplinary follow-up of patients treated for malignant hematological diseases. The patient-reported outcome measurements will be used in describing the patients' health-related quality of life (HRQoL) and to investigate whether the HRQol will increase due to participation in multidisciplinary follow-up.

Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease

Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease; Focus on the Patient's Preferences and Life Situation

Patients will be asked to electronically fill out questionnaires before each consultation.

The questionnaire that will be used to measure HRQoL is SF-36. SF-36 is a generic questionnaire which can be used to assess HRQoL in the general public.

Patients will be asked to electronically fill out questionnaires before each consultation.

The questionnaire that will be used to measure HRQoL is EORTC C30 QLQ. EORTC C30 QLQ is a disease specific questionnaire which can be used to assess HRQoL in patients diagnosed with cancer

Data on symptoms of depression and anxiety will be collected before and after each consultation using an international validated questionnaire.

The questionnaire which will be used is:

Hospital Depression and Anxiety Scale (HADS)

Data on symptoms of disease will be collected before each consultation using an international validated questionnaire.

The questionnaire which will be used is:

Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF)

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients	NCT03222258	Stage IV Breast... Stage IV Pancre... Stage IV Colon ... Stage IV Gastri... Stage IV Lung C... Stage IV Liver ... Malignant Hemat... Biliary Cancer ... Pediatric Leuke... Pediatric Lymph... Pediatric Brain... Pediatric Solid...	Early palliativ... Routine hospice...	-	Seoul National University Hospital
Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease	NCT03031106	Malignant Hemat...		18 Years -	Aalborg University Hospital
Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease	NCT03031106	Malignant Hemat...		18 Years -	Aalborg University Hospital
Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients	NCT03222258	Stage IV Breast... Stage IV Pancre... Stage IV Colon ... Stage IV Gastri... Stage IV Lung C... Stage IV Liver ... Malignant Hemat... Biliary Cancer ... Pediatric Leuke... Pediatric Lymph... Pediatric Brain... Pediatric Solid...	Early palliativ... Routine hospice...	-	Seoul National University Hospital

Spots Global Cancer Trial Database for malignant hematologic neoplasm